Document is current
Any future updates will be listed below
-
Authors
Lecronier, Marie https://orcid.org/0000-0002-5543-5074
Jung, Boris
Molinari, Nicolas
Pinot, Jérôme
Similowski, Thomas
Jaber, Samir
Demoule, Alexandre
Dres, Martin
- License Information
-
More Information
Article History
Received: 17 January 2022
Accepted: 18 March 2022
First Online: 11 April 2022
Declarations
:
: The protocols were, respectively, approved by the Comité de Protection des Personnes Ile de France VI and Sud-Méditerrannée II, Montpellier, France (N° 2014-A00715-42 et N° CCPPRB 06 04 03). All patients or their relatives provided written informed consent to participate.
: Not applicable.
: S. Jaber reports receiving consulting fees from Drager, Medtronic, Baxter, Fresenius, Xenios, and Fisher & Paykel. A. Demoule reports grants, personal fees and non-financial support from Philips, personal fees from Baxter, personal fees and non-financial support from Fisher & Paykel, grants from French Ministry of Health, personal fees from Getinge, grants, personal fees and non-financial support from Respinor, grants, personal fees and non-financial support from Lungpacer, personal fees from Lowenstein, personal fees from Gilead, outside the submitted work. M. Dres received fees from Lungpacer (expertise, lectures). The remaining authors have disclosed that they do not have any conflicts of interest.
